Soma Pharmacy Blognews

Archive for October 21st, 2009

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers [...]

Merck Frosst Canada announces the use of ISENTRESS for treating HIV-1 infected adults Merck Frosst Canada Ltd. is pleased to announce that (Pr)ISENTRESS(R) (raltegravir) is now indicated for use in treatment-naïve HIV-1 infected adults in combination with other antiretroviral agents.

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines Boehringer Ingelheim continues to be willing to provide WHO qualified generic pharmaceutical companies non assert declarations to manufacturer and export products containing the HIV/AIDS medication nevirapine to Rwanda and other defined developing countries.

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program TechnoVax, Inc., a biotechnology developer of novel vaccines was awarded a three-year $2.9 million SBIR phase II grant from the National Institutes of Health to further the development of its VLP-based, vaccine program.

Meeting to discuss latest information on anti-aging medicine and euthanasia America’s foremost authorities on aging will share the latest information on “death panels,” anti-aging medicine, health care reform, and other current topics at The Gerontological Society of America’s upcoming 62nd Annual Scientific Meeting. This four day event – the country’s largest interdisciplinary conference in the [...]

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda GlaxoSmithKline Inc. (GSK) As part of its broad commitment to improving access to medicines and its ongoing support for Canada’s Access to Medicines Regime (CAMR), GlaxoSmithKline confirms it will not object – through CAMR – to allow Canadian company (Apotex) to continue manufacturing their drug [...]

USP offers redesigned pharmaceutical standards format to improve key documentation process To improve key documentation relied upon by the pharmaceutical industry and others, the U.S. Pharmacopeial (USP) Convention announces the release of the redesigned United States Pharmacopeia-National Formulary (USP-NF).

Inovio Biomedical highlights its advances in electroporation-delivered SynCon DNA vaccines Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio’s Scientific Advisory Board, highlighted advances in electroporation-delivered SynCon™ DNA vaccines compared to other leading vaccine technologies at the AIDS Vaccine 2009 Conference being held [...]

Forget wine reviews: Colorado newspaper hiring a marijuana critic The store has a television lounge and a pool table, and snacks and acupuncture are free for customers who drop up to $130 an ounce on 16 varieties of marijuana .

Revised formula puts 1 in 6 Americans in poverty

Posted by: SomaNews on: 21 Oct, 2009

Revised formula puts 1 in 6 Americans in poverty The level of poverty in America is even worse than first believed. A revised formula for calculating medical costs and geographic variations show that approximately 47.4 million Americans last year lived in poverty, 7 million more than the government’s official figure.


canadian pharmacy

Categories


  • toby lee: There is some interesting data suggesting that keeping your vitamin D level optimal will prevent colds, flu and in particular H1N1 (swine Flu). The C
  • dalimmima: I think you made some good points in your post.
  • Acne Treatments Site: the H1N1 or Swine Flu Virus is very scary at first but now it is well controlled by vaccines and prevention by avoiding going into places with inciden
soma
ambien
duty free tobacco

Archives